People are buying semaglutide and tirzepatide, the key ingredients in Ozempic and Zepbound, from unconventional sources. Doctors have safety concerns.

Mounjaro and Ozempic are two medications that can help with diabetes and weight management. But is there a winner in the ...

A doctor has issued an warning as to why Ozempic shouldn't be used for weight loss as it does one alarming thing to body.

Investors are worried Novo Nordisk's competition with Eli Lilly is heating up and that the first-to-market GLP-1 leader is ...

Ozempic is hailed as a miracle drug by some people using it to lose weight, however, it isn't suitable for everyone and can ...

Hims & Hers stock has surged due to impressive quarterly results, rapid weight-loss product expansion, and a strategic Novo ...

From a celebrity-spruiked success to a relic of diet culture. How a changing world of nutrition led to Weight Watchers' bankruptcy.

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.